Cited by 603Dialysis and Renal Disease ManagementChronic Kidney Disease and DiabetesAcute Kidney Injury Research

Update on Inflammation in Chronic Kidney Disease

Akchurin, Oleh M., Kaskel, Frederick·2015·Blood Purification

Abstract

Background: Despite recent advances in chronic kidney disease (CKD) and end-stage renal disease (ESRD) management, morbidity and mortality in this population remain exceptionally high. Persistent, low-grade inflammation has been recognized as an important component of CKD, playing a unique role in its pathophysiology and being accountable in part for cardiovascular and all-cause mortality, as well as contributing to the development of protein-energy wasting. Summary: The variety of factors contribute to chronic inflammatory status in CKD, including increased production and decreased clearance of pro-inflammatory cytokines, oxidative stress and acidosis, chronic and recurrent infections, including those related to dialysis access, altered metabolism of adipose tissue, and intestinal dysbiosis. Inflammation directly correlates with the glomerular filtration rate (GFR) in CKD and culminates in dialysis patients, where extracorporeal factors, such as impurities in dialysis water, microbiological quality of the dialysate, and bioincompatible factors in the dialysis circuit play an additional role. Genetic and epigenetic influences contributing to inflammatory activation in CKD are currently being intensively investigated. A number of interventions have been proposed to target inflammation in CKD, including lifestyle modifications, pharmacological agents, and optimization of dialysis. Importantly, some of these therapies have been recently tested in randomized controlled trials. Key Messages: Chronic inflammation should be regarded as a common comorbid condition in CKD and especially in dialysis patients. A number of interventions have been proven to be safe and effective in well-designed clinical studies. This includes such inexpensive approaches as modification of physical activity and dietary supplementation. Further investigations are needed to evaluate the effects of these interventions on hard outcomes, as well as to better understand the role of inflammation in selected CKD populations (e.g., in children).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000368940

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bone-marrow-derived immune cells are activated by the gut microbiota, leading to low-grade inflammation that affects the brain, ANS and the kidney via the circulation.

    “Bone-marrow-derived immune cells are activated by the gut microbiota, leading to low-grade inflammation that affects the brain, ANS and the kidney via the circulation13–15.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Adamczak M, Chudek J, Wiecek A: Adipo- nectin in patients with chronic kidney disease. Semin Dial 2009; 22: 391-395.
  2. Panichi V, Paoletti S, Consani C: Inflamma- tory pattern in hemodiafiltration. Contrib Nephrol 2008; 161: 185-190.
  3. Wei M, Wang Z, Liu H, Jiang H, Wang M, Liang S, Shi K, Feng J: Probiotic Bifidobacte- rium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates mi- croinflammation in experimental uraemia. Nephrology (Carlton) 2014; 19: 500-506.
  4. Hung AM, Ellis CD, Shintani A, Booker C, Ikizler TA: IL-1beta receptor antagonist re- duces inflammation in hemodialysis patients. J Am Soc Nephrol 2011; 22: 437-442.

Cited by

Sorted by citations

Authors
Akchurin, O. M., & Kaskel, F.
Affiliations
  • Weill Cornell Medicine (US)
  • Albert Einstein College of Medicine (US)
Corresponding author
Akchurin, Oleh M.
Venue
Blood Purification
Publisher
S. Karger AG
Published
2015
Volume
39
Issue
1-3
Pages
84-92
ISSN
  • 0253-5068 (ISSN-L)
  • 1421-9735
OpenAlex
W2068629997
Cited by
603
References
97
Citations by year
2026: 24 · 2025: 59 · 2024: 66 · 2023: 93 · 2022: 77 · 2021: 66 · 2020: 50 · 2019: 62 · 2018: 62 · 2017: 25 · 2016: 14 · 2015: 4
FWCI
5.41
Type
journal article
Language
en
Open access
closed
Locations
  • Blood Purification (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
chronic kidney disease, inflammation, end-stage renal disease, dialysis, inflammatory cytokines, oxidative stress, acidosis, recurrent infections, hemodialysis vascular access, adipose tissue metabolism, gut dysbiosis, glomerular filtration rate, bioincompatibility, epigenetics, genetic factors, cardiovascular mortality, all-cause mortality, protein-energy wasting, physical activity, dietary supplementation, anti-inflammatory therapy
MeSH terms
Acidosis, Anti-Inflammatory Agents, Cardiovascular Diseases, Glomerular Filtration Rate, Renal Dialysis, Humans, Inflammation, Kidney Failure, Chronic, Exercise, Survival Analysis, Randomized Controlled Trials as Topic, Cytokines, Oxidative Stress, Wasting Syndrome, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review